ATE332964T1 - Mittels gewebetechnologie hergestellte dezellularisierte gegenstände und gewebe - Google Patents

Mittels gewebetechnologie hergestellte dezellularisierte gegenstände und gewebe

Info

Publication number
ATE332964T1
ATE332964T1 AT01964073T AT01964073T ATE332964T1 AT E332964 T1 ATE332964 T1 AT E332964T1 AT 01964073 T AT01964073 T AT 01964073T AT 01964073 T AT01964073 T AT 01964073T AT E332964 T1 ATE332964 T1 AT E332964T1
Authority
AT
Austria
Prior art keywords
construct
decellularized
tissue
objects
engineered
Prior art date
Application number
AT01964073T
Other languages
English (en)
Inventor
Shannon Mitchell
Jennifer Koh
Laura E Niklason
Vikas Prabhakar
Original Assignee
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Duke filed Critical Univ Duke
Application granted granted Critical
Publication of ATE332964T1 publication Critical patent/ATE332964T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Wood Science & Technology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT01964073T 2000-08-16 2001-08-16 Mittels gewebetechnologie hergestellte dezellularisierte gegenstände und gewebe ATE332964T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22569800P 2000-08-16 2000-08-16
US09/931,506 US6962814B2 (en) 2000-08-16 2001-08-16 Decellularized tissue engineered constructs and tissues

Publications (1)

Publication Number Publication Date
ATE332964T1 true ATE332964T1 (de) 2006-08-15

Family

ID=26919836

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01964073T ATE332964T1 (de) 2000-08-16 2001-08-16 Mittels gewebetechnologie hergestellte dezellularisierte gegenstände und gewebe

Country Status (7)

Country Link
US (4) US6962814B2 (de)
EP (1) EP1315796B1 (de)
AT (1) ATE332964T1 (de)
AU (1) AU2001284968B2 (de)
CA (1) CA2419817C (de)
DE (1) DE60121450T2 (de)
WO (1) WO2002014480A2 (de)

Families Citing this family (189)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485723B1 (en) 1995-02-10 2002-11-26 Purdue Research Foundation Enhanced submucosal tissue graft constructs
US8563232B2 (en) 2000-09-12 2013-10-22 Lifenet Health Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
US20080077251A1 (en) * 1999-06-07 2008-03-27 Chen Silvia S Cleaning and devitalization of cartilage
US6793677B2 (en) * 1999-08-13 2004-09-21 Bret A. Ferree Method of providing cells and other biologic materials for transplantation
US20040043006A1 (en) * 2002-08-27 2004-03-04 Badylak Stephen F. Tissue regenerative composition
US6576265B1 (en) * 1999-12-22 2003-06-10 Acell, Inc. Tissue regenerative composition, method of making, and method of use thereof
AU2001284968B2 (en) * 2000-08-16 2006-12-21 Duke University Decellularized tissue engineered constructs and tissues
US6599526B2 (en) * 2000-08-18 2003-07-29 The University Of North Texas Health Science Center At Fort Worth Pericardial anti-adhesion patch
US20020146817A1 (en) * 2000-10-02 2002-10-10 Cannon Thomas F. Automated bioculture and bioculture experiments system
US20040151705A1 (en) * 2002-03-22 2004-08-05 Shuichi Mizuno Neo-cartilage constructs and a method for preparation thereof
GB2375771A (en) * 2001-05-24 2002-11-27 Univ Leeds Decellularisation of tissue implant material
US7297540B2 (en) * 2002-01-15 2007-11-20 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods of generating tissue using devitalized, acellular scaffold matrices derived from micro-organs
WO2003070084A2 (en) * 2002-02-19 2003-08-28 Bioarttis, Inc. Artificial vessel scaffold and artificial organs therefrom
US20030187515A1 (en) * 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
EP1503652A4 (de) 2002-05-02 2006-02-08 Purdue Research Foundation Durch vaskularisierung verstärkte prothesenkonstrukte
EP1503789A4 (de) * 2002-05-02 2006-08-02 Purdue Research Foundation Durch vaskularisierung verstärkte prothesenkonstrukte
CN1684589A (zh) 2002-05-02 2005-10-19 普渡研究基金会 血管化增强的移植构造物
EP1585426A4 (de) * 2002-05-02 2006-09-20 Cook Biotech Inc Mit zellen beimpfte extrazelluläre matrix-transplantate
US20040072294A1 (en) * 2002-06-19 2004-04-15 Braunhut Susan J. Tissue reconstruction and regeneration
US11243494B2 (en) 2002-07-31 2022-02-08 Abs Global, Inc. Multiple laminar flow-based particle and cellular separation with laser steering
JP4092397B2 (ja) * 2002-09-10 2008-05-28 国立循環器病センター総長 超高静水圧印加による移植用生体組織の処理方法
WO2004030626A2 (en) * 2002-09-30 2004-04-15 Massachussetts Eye & Ear Infirmary In vitro culture of tissue structures
US20040151729A1 (en) * 2002-10-28 2004-08-05 George Michalopoulos Novel long-term three-dimensional culture system
US20040176855A1 (en) * 2003-03-07 2004-09-09 Acell, Inc. Decellularized liver for repair of tissue and treatment of organ deficiency
US20040175366A1 (en) * 2003-03-07 2004-09-09 Acell, Inc. Scaffold for cell growth and differentiation
US8367410B2 (en) * 2003-06-20 2013-02-05 Massachusetts Institute Of Technology Application of electrical stimulation for functional tissue engineering in vitro and in vivo
AU2004253508A1 (en) 2003-06-25 2005-01-13 Acell, Inc. Conditioned matrix compositions for tissue restoration
US7326571B2 (en) * 2003-07-17 2008-02-05 Boston Scientific Scimed, Inc. Decellularized bone marrow extracellular matrix
US20050013870A1 (en) * 2003-07-17 2005-01-20 Toby Freyman Decellularized extracellular matrix of conditioned body tissues and uses thereof
DE10333863A1 (de) * 2003-07-24 2005-02-17 Walles, Thorsten Dr. Med. Bioartifizielles, primär vaskularisiertes Testgewebe für pharmakologische Testverfahren, Verfahren zu dessen Herstellung und Testverfahren unter dessen Verwendung sowie Bioreaktor zur Durchführung der Verfahren
US7744869B2 (en) * 2003-08-20 2010-06-29 Ebi, Llc Methods of treatment using electromagnetic field stimulated mesenchymal stem cells
AU2004269405A1 (en) * 2003-09-02 2005-03-10 University Of North Carolina At Chapel Hill Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells
GB2423934B (en) * 2003-09-04 2007-11-28 Cook Biotech Inc Extracellular matrix composite materials, and manufacture and use thereof
US20050125049A1 (en) * 2003-10-21 2005-06-09 The Regents Of The University Of Michigan Tissue engineered vascular construct and method for producing same
US7840263B2 (en) 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
JP2007529278A (ja) * 2004-03-17 2007-10-25 レビビコア， インコーポレイテッド 機能的α１，３ガラクトシルトランスフェラーゼを欠く動物に由来する組織生成物
US20050266390A1 (en) * 2004-06-01 2005-12-01 Yuichiro Ueda Processes for removing cells and cell debris from tissue and tissue constructs used in transplantation and tissue reconstruction
WO2005118014A2 (en) * 2004-06-01 2005-12-15 Medtronic, Inc. Decellurisation processes for making bioprotheses
US7764995B2 (en) 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
US8060219B2 (en) 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
US8874204B2 (en) * 2004-12-20 2014-10-28 Cardiac Pacemakers, Inc. Implantable medical devices comprising isolated extracellular matrix
US7981065B2 (en) 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
US20060172315A1 (en) * 2005-02-01 2006-08-03 Anderson Amy L Methods for staining cells for identification and sorting
EP1693025A1 (de) 2005-02-17 2006-08-23 Universität Zürich Verfahren zur Herstellung einer Prothese aus Gewebe
US8445278B2 (en) * 2005-03-01 2013-05-21 Medtronic, Inc. Process for producing decellularized biological tissues
WO2006095342A2 (en) * 2005-03-07 2006-09-14 Technion Research & Development Foundation Ltd. Natural tissue-derived decellularized matrix and methods of generating and using same
US9493735B2 (en) * 2005-04-15 2016-11-15 Wake Forest University Health Sciences Bioreactor system and method of enhancing functionality of muscle cultured in vitro
DE102005023599A1 (de) * 2005-05-18 2006-11-23 Corlife Gbr (Vertretungsberechtigte Gesellschafter: Prof. Dr. Alex Haverich Bioartifizielles Herzgewebetransplantat und Verfahren zu seiner Herstellung
US7840272B2 (en) 2005-06-03 2010-11-23 Medrelief Inc. Methods for modulating osteochondral development using bioelectrical stimulation
WO2007005807A2 (en) * 2005-06-30 2007-01-11 Anthrogenesis Corporation Repair of tympanic membrane using placenta derived collagen biofabric
US20100093066A1 (en) * 2005-08-26 2010-04-15 Regents Of The University Of Minnesota Decellularization and recellularization apparatuses and systems containing the same
SG170731A1 (en) * 2005-08-26 2011-05-30 Univ Minnesota Decellularization and recellularization of organs and tissues
US8921109B2 (en) 2005-09-19 2014-12-30 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
EP1965812A4 (de) * 2005-11-08 2010-02-24 Georgia Tech Res Inst Azellularisiertes biologisches material aus embryonalen stammzellen
EP2031968B1 (de) * 2006-04-21 2017-11-22 Wake Forest University Health Sciences Strukturell modifizierte azelluläre gewebe-engineering-gerüste und herstellungsverfahren
WO2008021391A1 (en) * 2006-08-15 2008-02-21 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
KR100816395B1 (ko) * 2006-09-21 2008-03-27 (주)필미아젠 세포 유래 세포외기질막의 제조방법
WO2008060377A2 (en) 2006-10-04 2008-05-22 Anthrogenesis Corporation Placental or umbilical cord tissue compositions
EP2076279B1 (de) 2006-10-06 2014-08-27 Anthrogenesis Corporation Native (telopeptid) plazentare kollagenzusammensetzungen
US8105380B2 (en) * 2006-10-23 2012-01-31 Stemedica Cell Technologies, Inc. Cellular scaffold
US8709081B2 (en) 2006-10-23 2014-04-29 Stemedica Cell Technologies, Inc. Cellular scaffold
ES2372116T3 (es) * 2006-11-16 2012-01-16 The University Of Leeds Preparación de tejido para implantación meniscal.
US8097455B2 (en) * 2007-02-02 2012-01-17 The Regents Of The University Of Michigan System and method for forming skeletal muscle constructs having functional tissue interfaces
WO2008109407A2 (en) 2007-03-02 2008-09-12 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Extracellular matrix-derived gels and related methods
SG10201509679XA (en) 2007-05-29 2015-12-30 Christopher B Reid Methods for production and uses of multipotent cell populations
US8685107B2 (en) 2007-07-03 2014-04-01 Histogenics Corporation Double-structured tissue implant and a method for preparation and use thereof
US20090054984A1 (en) 2007-08-20 2009-02-26 Histogenics Corporation Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects
US9125743B2 (en) * 2007-07-16 2015-09-08 Lifenet Health Devitalization and recellularization of cartilage
US9744043B2 (en) 2007-07-16 2017-08-29 Lifenet Health Crafting of cartilage
WO2009017646A2 (en) 2007-07-27 2009-02-05 Humacyte, Inc. Compositions comprising human collagen and human elastin and methods for soft tissue augmentation
WO2009026392A1 (en) 2007-08-20 2009-02-26 Histogenics Corporation A method for improvement of differentiation of mesenchymal stem cells using a double-structured tissue implant
US20100227523A1 (en) * 2007-09-14 2010-09-09 Exogenesis Corporation Methods for improving the bioactivity characteristics of a surface and objects with surfaces improved thereby
US8377460B2 (en) * 2007-09-14 2013-02-19 Exogenesis Corporation Method for modifying the wettability and/or other biocompatibility characteristics of a surface of a biological material by the application of gas cluster ion beam technology and biological materials made thereby
US9144627B2 (en) 2007-09-14 2015-09-29 Exogenesis Corporation Methods for improving the bioactivity characteristics of a surface and objects with surfaces improved thereby
JP5107680B2 (ja) * 2007-11-16 2012-12-26 パナソニック株式会社 半導体装置
CN101274106B (zh) * 2008-03-24 2011-11-09 中山大学中山眼科中心 一种制备脱细胞基质的方法
US20130116799A1 (en) * 2008-03-27 2013-05-09 The Cleveland Clinic Foundation Reinforced tissue graft
US9283051B2 (en) 2008-04-29 2016-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating a treatment volume for administering electrical-energy based therapies
US10245098B2 (en) 2008-04-29 2019-04-02 Virginia Tech Intellectual Properties, Inc. Acute blood-brain barrier disruption using electrical energy based therapy
US8992517B2 (en) 2008-04-29 2015-03-31 Virginia Tech Intellectual Properties Inc. Irreversible electroporation to treat aberrant cell masses
US11272979B2 (en) 2008-04-29 2022-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US9867652B2 (en) 2008-04-29 2018-01-16 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
US10272178B2 (en) 2008-04-29 2019-04-30 Virginia Tech Intellectual Properties Inc. Methods for blood-brain barrier disruption using electrical energy
US10448989B2 (en) 2009-04-09 2019-10-22 Virginia Tech Intellectual Properties, Inc. High-frequency electroporation for cancer therapy
AU2009243079A1 (en) * 2008-04-29 2009-11-05 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation to create tissue scaffolds
US9198733B2 (en) 2008-04-29 2015-12-01 Virginia Tech Intellectual Properties, Inc. Treatment planning for electroporation-based therapies
US10702326B2 (en) 2011-07-15 2020-07-07 Virginia Tech Intellectual Properties, Inc. Device and method for electroporation based treatment of stenosis of a tubular body part
US10238447B2 (en) 2008-04-29 2019-03-26 Virginia Tech Intellectual Properties, Inc. System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
US11254926B2 (en) 2008-04-29 2022-02-22 Virginia Tech Intellectual Properties, Inc. Devices and methods for high frequency electroporation
US10117707B2 (en) 2008-04-29 2018-11-06 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
WO2009152174A1 (en) * 2008-06-09 2009-12-17 The Children's Mercy Hospital Tissue retaining system
CN103751842A (zh) * 2008-07-30 2014-04-30 米辛瑟斯有限公司 衍生自前胃胞外基质的组织支架
KR20110102930A (ko) * 2008-12-31 2011-09-19 케이씨아이 라이센싱 인코포레이티드 신경 조직에 유체 흐름을 제공하기 위한 시스템
EP2393914B1 (de) * 2009-02-04 2017-01-04 Yale University Lungengewebekonstruktion
US8628572B2 (en) 2009-02-26 2014-01-14 Wake Forest University Health Sciences Corneal endothelial scaffolds and methods of use
US8685634B2 (en) * 2009-03-06 2014-04-01 University of Pittsburgh—of the Commonwealth System of Higher Education Neural scaffolds
WO2010105102A1 (en) * 2009-03-11 2010-09-16 Exogenesis Corporation Methods for improving the bioactivity characteristics of a surface and objects with surfaces improved thereby
US8173420B2 (en) 2009-03-11 2012-05-08 Tissue Growth Technologies Corporation Cell seeding module
EP2405891B1 (de) * 2009-03-11 2019-07-03 Exogenesis Corporation Verfahren zur modifikation der befeuchtbarkeit und/oder anderer biokompatibilitätseigenschaften der oberfläche eines biologischen materials durch anwendung einer gascluster-ionenstrahltechnologie sowie in diesem verfahren hergestellte biologische materialien
WO2010111263A1 (en) 2009-03-23 2010-09-30 Wake Forest University Health Sciences Tissue engineering scaffolds and methods of use
US11638603B2 (en) 2009-04-09 2023-05-02 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
WO2010118387A1 (en) 2009-04-09 2010-10-14 Virginia Tech Intellectual Properties, Inc. Integration of very short electric pulses for minimally to noninvasive electroporation
US11382681B2 (en) 2009-04-09 2022-07-12 Virginia Tech Intellectual Properties, Inc. Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
US20100267143A1 (en) * 2009-04-16 2010-10-21 Snu R&Db Foundation Method for Surface Modification of Polymeric Scaffold for Stem Cell Transplantation Using Decellularized Extracellular Matrix
AU2010249805B2 (en) * 2009-05-20 2015-06-11 Humacyte, Inc. Elastin for soft tissue augmentation
WO2010138919A2 (en) 2009-05-28 2010-12-02 Angiodynamics, Inc. System and method for synchronizing energy delivery to the cardiac rhythm
US9895189B2 (en) 2009-06-19 2018-02-20 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation
US8298586B2 (en) 2009-07-22 2012-10-30 Acell Inc Variable density tissue graft composition
US8652500B2 (en) 2009-07-22 2014-02-18 Acell, Inc. Particulate tissue graft with components of differing density and methods of making and using the same
US8507263B2 (en) * 2009-08-07 2013-08-13 Maria Adelaide Asnaghi Rotating bioreactor
AU2010324536B2 (en) * 2009-11-27 2016-03-03 Stephen Anthony Livesey A method of inducing cellular growth and materials for use therewith
HUE032727T2 (en) 2010-07-02 2017-10-30 Marsha Lynn Roach Biometric skeletons for industrial scale dispersion
CA2807762C (en) 2010-08-13 2023-08-08 Wake Forest University Health Sciences Methods for making a tissue engineered muscle repair (temr) construct in vitro for implantation in vivo
EP2611472B1 (de) 2010-09-01 2016-02-10 Regents of the University of Minnesota Verfahren zur rezellularisierung eines gewebes oder organs für verbesserte tranplantationsfähigkeit
US9700368B2 (en) 2010-10-13 2017-07-11 Angiodynamics, Inc. System and method for electrically ablating tissue of a patient
US10908066B2 (en) 2010-11-16 2021-02-02 1087 Systems, Inc. Use of vibrational spectroscopy for microfluidic liquid measurement
ES2724587T3 (es) 2011-01-06 2019-09-12 Humacyte Inc Constructos generados por ingeniería de tejidos
US20130013083A1 (en) * 2011-01-06 2013-01-10 Humacyte Tissue-Engineered Constructs
US9238793B2 (en) 2011-04-28 2016-01-19 Lifecell Corporation Method for enzymatic treatment of tissue products
US10207025B2 (en) 2011-04-28 2019-02-19 Lifecell Corporation Method for enzymatic treatment of tissue products
ES2720137T3 (es) * 2011-04-28 2019-07-18 Lifecell Corp Método para el tratamiento enzimático de productos tisular
CN102260731B (zh) * 2011-06-28 2015-03-25 合肥安旸生物医药有限公司 用于膀胱癌筛查的酶标液基细胞学染色试剂盒
WO2013009595A2 (en) * 2011-07-08 2013-01-17 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Injectable cns-derived ecm for tissue reconstruction
JP2014525817A (ja) 2011-08-22 2014-10-02 エクソジェネシス コーポレーション 物体表面の生物活性特徴の向上方法ならびにそれにより向上された表面
US9114195B2 (en) 2011-08-22 2015-08-25 Exogenesis Corporation Method for modifying the wettability and other biocompatibility characteristics of a surface of a biological material by the application of beam technology and biological materials made thereby
US9078665B2 (en) 2011-09-28 2015-07-14 Angiodynamics, Inc. Multiple treatment zone ablation probe
WO2013052138A2 (en) * 2011-10-03 2013-04-11 Fabrico. Inc. System and method for electrophoretic decellularization
ES2719128T3 (es) * 2011-10-14 2019-07-08 Humacyte Inc Prótesis tubulares
EP2773388A4 (de) 2011-11-02 2015-07-15 Mimedx Group Inc Implantierbare kollagenvorrichtungen sowie verfahren und systeme zu ihrer herstellung
US20130165384A1 (en) * 2011-12-14 2013-06-27 Edmund Burke Decellularized small particle tissue
US9606035B2 (en) 2011-12-21 2017-03-28 Ta Instruments-Waters Llc System for mechanical stimulation and characterization of biologic samples
EP2809152B1 (de) 2012-02-01 2019-11-20 Nayacure Therapeutics Ltd Verfahren zur induktion von immuntoleranz bei organtransplantationen
WO2013163358A1 (en) 2012-04-24 2013-10-31 Harvard Bioscience, Inc. Engineered tissue scaffolds and supports therefor
US20130344490A1 (en) * 2012-04-27 2013-12-26 Min Peter Kim Neoplastic cells grown on decellularized biomatrix
US9290738B2 (en) 2012-06-13 2016-03-22 Miromatrix Medical Inc. Methods of decellularizing bone
ES2778029T3 (es) * 2012-06-14 2020-08-07 Greiner Bio-One North America Inc Matriz extracelular magnética
US20140023722A1 (en) * 2012-07-20 2014-01-23 Alan V. Boruch Neural Scaffold Biomaterial
EP2943231A4 (de) 2013-01-09 2016-12-07 Harvard Apparatus Regenerative Tech Inc Synthetische gerüste
US9888956B2 (en) 2013-01-22 2018-02-13 Angiodynamics, Inc. Integrated pump and generator device and method of use
CN103041450B (zh) * 2013-01-25 2015-06-10 南通大学 用于修复周围神经损伤的细胞基质修饰的组织工程神经移植物及其制备方法
BR112015023642A2 (pt) 2013-03-15 2017-07-18 Miromatrix Medical Inc uso de perfusão de fígado descelularizado para permitir recelularização de célula
WO2014145854A1 (en) * 2013-03-15 2014-09-18 University Of Florida Research Foundation, Inc. Method for decellularization of tissue grafts
CN104278008B (zh) 2013-07-12 2020-08-21 北京宏冠再生医学科技有限公司 一种通过小分子化合物处理来制备多潜能干细胞的方法、试剂盒和用途
US8961904B2 (en) 2013-07-16 2015-02-24 Premium Genetics (Uk) Ltd. Microfluidic chip
US9878071B2 (en) 2013-10-16 2018-01-30 Purdue Research Foundation Collagen compositions and methods of use
US11796449B2 (en) 2013-10-30 2023-10-24 Abs Global, Inc. Microfluidic system and method with focused energy apparatus
CA2925332C (en) 2013-11-04 2022-07-12 Lifecell Corporation Methods of removing alpha-galactose
KR101636954B1 (ko) * 2013-11-04 2016-07-08 대한민국 재세포화된 바이오 스캐폴드 및 이의 제조방법
WO2015134618A1 (en) * 2014-03-04 2015-09-11 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Method and apparatus for decellularization of tissue
AU2015231110B2 (en) 2014-03-21 2019-03-07 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods for preparation of a terminally sterilized hydrogel derived from extracellular matrix
CN112807074A (zh) 2014-05-12 2021-05-18 弗吉尼亚暨州立大学知识产权公司 电穿孔系统
US10293082B2 (en) 2014-07-23 2019-05-21 Clemson University Research Foundation Decellularization method and system and decellularized tissue formed thereby
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
WO2016100325A1 (en) 2014-12-15 2016-06-23 Virginia Tech Intellectual Properties, Inc. Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
US10988735B2 (en) 2015-01-16 2021-04-27 Clemson University Research Foundation Cardiac tissues containing semiconductor nanomaterials and methods of preparing and using the same
WO2016132222A2 (en) 2015-02-19 2016-08-25 Premium Genetics (Uk) Ltd. Scanning infrared measurement system
CN104800890B (zh) * 2015-04-08 2017-05-17 中山大学 一种脱细胞颌下腺基质材料及其制备方法
US11919941B2 (en) 2015-04-21 2024-03-05 Purdue Research Foundation Cell-collagen-silica composites and methods of making and using the same
US20180228599A1 (en) * 2015-08-06 2018-08-16 The Johns Hopkins University Tissue-derived scaffolds for corneal reconstruction
CN108884436B (zh) 2015-08-13 2021-11-05 北昊干细胞与再生医学研究院有限公司 诱导的扩展的多潜能干细胞、制备及使用方法
WO2017091943A1 (en) 2015-11-30 2017-06-08 Hong Guan Ltd. Improved methods for reprograming non-pluripotent cells into pluripotent stem cells
US11458224B2 (en) * 2016-03-04 2022-10-04 University of Pittsburgh—of the Commonwealth System of Higher Education Ovarian-derived hydrogels for biomedical and biotechnology applications
CN109715140B (zh) 2016-06-15 2022-06-24 通用医疗公司 使用生物正交反应进行的生物材料的代谢标记和分子增强
WO2018048899A1 (en) 2016-09-06 2018-03-15 Micromatrix Medical Inc. Use of resected liver serum for whole liver engineering
GB2555787A (en) 2016-11-07 2018-05-16 Landberg Goran Diagnostic methods
US10905492B2 (en) 2016-11-17 2021-02-02 Angiodynamics, Inc. Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
EP3573675A1 (de) 2017-01-30 2019-12-04 LifeCell Corporation Gewebematrixmaterialien und enzymatische klebstoffe
US10413634B2 (en) 2017-01-30 2019-09-17 Lifecell Corporation Transglutaminase treated products
CA3052489A1 (en) 2017-03-02 2018-09-07 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Ecm hydrogel for treating esophageal inflammation
ES2931299T3 (es) 2017-03-02 2022-12-28 Univ Pittsburgh Commonwealth Sys Higher Education Hidrogel de matriz extracelular (ECM) y fracción soluble del mismo para su utilización en el tratamiento del cáncer
US10767164B2 (en) 2017-03-30 2020-09-08 The Research Foundation For The State University Of New York Microenvironments for self-assembly of islet organoids from stem cells differentiation
WO2018200750A1 (en) 2017-04-25 2018-11-01 Purdue Research Foundation 3-dimensional (3d) tissue-engineered muscle for tissue restoration
WO2018218480A1 (en) 2017-05-31 2018-12-06 Beihao Stem Cell And Regenerative Medicine Research Institute Co., Ltd. Methods for chemically induced lineage reprogramming
ES2943332T3 (es) 2017-09-04 2023-06-12 Univ Zuerich Producto sanitario de ingeniería tisular
US11607537B2 (en) 2017-12-05 2023-03-21 Virginia Tech Intellectual Properties, Inc. Method for treating neurological disorders, including tumors, with electroporation
US11311329B2 (en) 2018-03-13 2022-04-26 Virginia Tech Intellectual Properties, Inc. Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
US11925405B2 (en) 2018-03-13 2024-03-12 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation
BR112020023607A2 (pt) 2018-05-23 2021-02-17 Abs Global, Inc. sistemas e métodos para focalização de partículas em microcanais
CN109453427A (zh) * 2018-11-30 2019-03-12 广州新诚生物科技有限公司 一种动物组织脱细胞化前的清洗方法
WO2020131661A1 (en) * 2018-12-21 2020-06-25 Trustees of Tuffs College In vitro insect muscle as a nutrition source
WO2020215011A1 (en) 2019-04-18 2020-10-22 Abs Global, Inc. System and process for continuous addition of cryoprotectant
US11950835B2 (en) 2019-06-28 2024-04-09 Virginia Tech Intellectual Properties, Inc. Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy
US11628439B2 (en) 2020-01-13 2023-04-18 Abs Global, Inc. Single-sheath microfluidic chip
CN115698262A (zh) 2020-03-30 2023-02-03 阿卜杜拉国王科技大学 用于控制细胞身份的组合物和方法
GB2601793A (en) 2020-12-10 2022-06-15 The Francis Crick Institute Ltd Thymic constructs and uses thereof
US11376347B1 (en) * 2021-06-21 2022-07-05 The Florida International University Board Of Trustees Materials and methods for accelerating cardiovascular tissue regeneration
GB202203756D0 (en) 2022-03-17 2022-05-04 Francis Crick Institute Ltd Thymic epithelial stem cells
EP4252790A1 (de) 2022-03-30 2023-10-04 Nordovo Biosciences As Verwendung von mikroträgern auf polymerbasis bei der produktion von gewebegerüsten mit komplexer geometrie
CN115227868B (zh) * 2022-07-20 2023-07-07 中南大学湘雅医院 骨缺损修复材料及镁预处理脱细胞组织工程骨支架

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US564756A (en) * 1896-07-28 Plant for heating greenhouses
US4559298A (en) 1982-11-23 1985-12-17 American National Red Cross Cryopreservation of biological materials in a non-frozen or vitreous state
US4801299A (en) * 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
US5266480A (en) * 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
GB8618374D0 (en) 1986-07-28 1986-09-03 Hsc Res Dev Corp Biological vascular prostheses
CA1340581C (en) 1986-11-20 1999-06-08 Joseph P. Vacanti Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
US4890457A (en) 1987-01-02 1990-01-02 Cryolife, Inc. Method for cryopreserving heart valves
US5145769A (en) 1987-08-21 1992-09-08 Cryolife Inc. Method for cryopreserving blood vessels
US5158867A (en) 1987-08-21 1992-10-27 Cryolife Inc. Method for cryopreserving blood vessels
USD323895S (en) 1989-04-13 1992-02-11 Lifecell Corporation Cryo slammer for cooling tissue samples
US5131850A (en) 1989-11-03 1992-07-21 Cryolife, Inc. Method for cryopreserving musculoskeletal tissues
US5336616A (en) 1990-09-12 1994-08-09 Lifecell Corporation Method for processing and preserving collagen-based tissues for transplantation
AU650045B2 (en) 1990-09-12 1994-06-09 Lifecell Corporation Method and apparatus for cryopreparation dry stabilization and rehydration of biological suspensions
US5192312A (en) 1991-03-05 1993-03-09 Colorado State University Research Foundation Treated tissue for implantation and methods of treatment and use
DE69131423T2 (de) 1991-03-08 2000-01-20 Keiji Igaki Stent für gefässe, halterungsstruktur für diesen stent und vorrichtung zur montage desselben
US5217860A (en) 1991-07-08 1993-06-08 The American National Red Cross Method for preserving organs for transplantation by vitrification
US5723282A (en) 1991-07-08 1998-03-03 The American National Red Cross Method of preparing organs for vitrification
US5800537A (en) * 1992-08-07 1998-09-01 Tissue Engineering, Inc. Method and construct for producing graft tissue from an extracellular matrix
AU1931495A (en) * 1994-03-14 1995-10-03 Cryolife, Inc. Treated tissue for implantation and preparation methods
US5916265A (en) 1994-03-30 1999-06-29 Hu; Jie Method of producing a biological extracellular matrix for use as a cell seeding scaffold and implant
US5595571A (en) 1994-04-18 1997-01-21 Hancock Jaffe Laboratories Biological material pre-fixation treatment
EP0757562A1 (de) * 1994-04-29 1997-02-12 W.L. Gore & Associates, Inc. Blutkontaktoberfläche unter verwendung von endothel auf einer subendotelialen extrazellulären matrix
US5716394A (en) * 1994-04-29 1998-02-10 W. L. Gore & Associates, Inc. Blood contact surfaces using extracellular matrix synthesized in vitro
US5622867A (en) 1994-10-19 1997-04-22 Lifecell Corporation Prolonged preservation of blood platelets
ZA963151B (en) * 1995-04-19 1997-04-24 St Jude Medical Matrix substrate for a viable body tissue-derived prosthesis and method for making the same
US5830708A (en) * 1995-06-06 1998-11-03 Advanced Tissue Sciences, Inc. Methods for production of a naturally secreted extracellular matrix
CA2230263A1 (en) 1995-08-25 1997-03-06 Lifecell Corporation Reconstituted skin
WO1997046266A1 (en) * 1996-06-03 1997-12-11 Gore Enterprise Holdings, Inc. Improved blood contact surfaces using extracellular matrix synthesized in vitro having bioactive species immobilized thereto
US5952168A (en) 1996-11-07 1999-09-14 21St Century Medicine, Inc. Method for vitrification of biological materials using alkoxylated compounds
US5899937A (en) 1997-03-05 1999-05-04 Cryolife, Inc. Pulsatile flow system for developing heart valves
ES2231980T3 (es) 1997-04-11 2005-05-16 Cryolife, Inc. Descelurizacion de un tejido.
US6179872B1 (en) * 1998-03-17 2001-01-30 Tissue Engineering Biopolymer matt for use in tissue repair and reconstruction
US6743574B1 (en) * 2000-09-12 2004-06-01 Lifenet Process for devitalizing soft-tissue engineered medical implants, and devitalized soft-tissue medical implants produced
US6734018B2 (en) * 1999-06-07 2004-05-11 Lifenet Process for decellularizing soft-tissue engineered medical implants, and decellularized soft-tissue medical implants produced
WO2001014557A1 (en) 1999-08-23 2001-03-01 Dana-Farber Cancer Institute, Inc. Pd-1, a receptor for b7-4, and uses therefor
US6432712B1 (en) * 1999-11-22 2002-08-13 Bioscience Consultants, Llc Transplantable recellularized and reendothelialized vascular tissue graft
US6503273B1 (en) * 1999-11-22 2003-01-07 Cyograft Tissue Engineering, Inc. Tissue engineered blood vessels and methods and apparatus for their manufacture
US6376244B1 (en) 1999-12-29 2002-04-23 Children's Medical Center Corporation Methods and compositions for organ decellularization
US6866686B2 (en) * 2000-01-28 2005-03-15 Cryolife, Inc. Tissue graft
US6652583B2 (en) * 2000-04-07 2003-11-25 Rhode Island Hospital Cardiac valve replacement
ATE390152T1 (de) * 2000-04-28 2008-04-15 Baylor College Medicine Dezellularisierte gefässprothesen
AU2001284968B2 (en) * 2000-08-16 2006-12-21 Duke University Decellularized tissue engineered constructs and tissues
AU2002247127A1 (en) * 2001-02-14 2002-08-28 Duke University Therapy for cerebral vasospasm
US7504258B2 (en) * 2001-12-11 2009-03-17 Cytograft Tissue Engineering, Inc. Tissue engineered cellular sheets, methods of making and use thereof
US7943378B2 (en) 2002-03-15 2011-05-17 Duke University Tissue engineering
CA2602029C (en) * 2005-03-11 2014-07-15 Wake Forest University Health Sciences Tissue engineered blood vessels
WO2007070301A2 (en) * 2005-12-05 2007-06-21 Regeneration Technologies, Inc. Vascular graft sterilization and decellularization
GB0606231D0 (en) * 2006-03-29 2006-05-10 Univ Leeds Improvements relating to decellurisation of tissue matrices for bladder implantation

Also Published As

Publication number Publication date
CA2419817C (en) 2014-11-18
DE60121450T2 (de) 2007-02-15
US20080248080A1 (en) 2008-10-09
AU2001284968B2 (en) 2006-12-21
US6962814B2 (en) 2005-11-08
US20060073590A1 (en) 2006-04-06
WO2002014480A2 (en) 2002-02-21
EP1315796A2 (de) 2003-06-04
WO2002014480A9 (en) 2003-03-27
CA2419817A1 (en) 2002-02-21
WO2002014480A3 (en) 2002-08-01
DE60121450D1 (de) 2006-08-24
EP1315796B1 (de) 2006-07-12
US20120135049A1 (en) 2012-05-31
US20020115208A1 (en) 2002-08-22

Similar Documents

Publication Publication Date Title
ATE332964T1 (de) Mittels gewebetechnologie hergestellte dezellularisierte gegenstände und gewebe
DK1201749T3 (da) Fremgangsmåde til fremstilling af humane bruskimplantater ved hjælp af in vitro dyrkede chondrocytter
IL144446A0 (en) Plasma protein matrices and methods for their preparation
MXPA04004534A (es) Aumento de la funcion de un organo.
WO2002067867A3 (en) Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair
WO2007124127A3 (en) Structurally modified acellular tissue engineering scaffolds and methods of production
WO2003082201A3 (en) Collagen biofabric and methods of preparation and use therefor
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
WO2005007233A3 (en) Application of electrical stimulation for functional tissue engineering in vitro and in vivo
EP2266500A3 (de) Dreidimensional Gewebe-Struktur
DK1311658T3 (da) Fremgangsmåde til fremstilling af brugsfærdige, eventuelt antigenholdige cryokonserverede modne dendritiske celler
DE602005025487D1 (de) Zellunabhängige herstellung von gewebeäquivalenten
ATE553186T1 (de) Bandscheibenreparatur und verfahren dafür
ATE402002T1 (de) Elektroverarbeitetes kollagen
EP2172231A4 (de) Durch tissue-engineering hergestellte sehne und in vitro konstruktionsverfahren dafür
ATE500318T1 (de) Gerüstlose konstrukte für die erzeugung von gelenkknorpel aus gewebe
WO2005046445A3 (en) Artificial tissue systems and uses thereof
FR2985170B1 (fr) Prothese pour hernie inguinale
CY1111368T1 (el) Προαγγειοποιημενα μοσχευματα ιστου για την αναδομηση ενος ανθρωπινου ή ζωικου οργανου
CO5570711A2 (es) Metodo para preparar heparina de cultivos de mastocitos
BR112022003045A2 (pt) Métodos para determinar a adequação de tecido de timo cultivado para o implante em humanos e métodos de uso associados
ATE384123T1 (de) Verfahren zur herstellung eines empfängerspezifischen gewebe-transplantats oder - implantats
CN103157136A (zh) 一种组织工程化瓣膜
CL2022001580A1 (es) Espuma de aleación en base a titanio; método de preparación y su uso como biomaterial
JP2006204530A (ja) 生体組織に含まれる細胞量を減少させる方法及び無細胞化された生体組織

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties